A citation-based method for searching scientific literature

Guilherme Suarez-Kurtz. Clinics (Sao Paulo) 2018
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.
Vid Mlakar, Patricia Huezo-Diaz Curtis, Chakradhara Rao Satyanarayana Uppugunduri, Maja Krajinovic, Marc Ansari. Int J Mol Sci 2016
12
33

Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.
Alexandre Vivot, Isabelle Boutron, Philippe Ravaud, Raphaël Porcher. Genet Med 2015
25
33

Pharmacogenomic biomarker information in FDA-approved paediatric drug labels.
Therasa Kim, Nayoung Han, Minji Sohn, Jung Mi Oh, Eui-Kyung Lee, Eunhee Ji, In-Wha Kim. Basic Clin Pharmacol Toxicol 2015
7
33

Similarities and differences between US and Japan as to pharmacogenomic biomarker information in drug labels.
Yasuto Otsubo, Yasuko Asahina, Atsushi Noguchi, Yumiko Sato, Yuki Ando, Yoshiaki Uyama. Drug Metab Pharmacokinet 2012
18
33


European Medicines Agency initiatives and perspectives on pharmacogenomics.
Falk Ehmann, Laura Caneva, Marisa Papaluca. Br J Clin Pharmacol 2014
18
33

Pharmacogenomic information in drug labels: European Medicines Agency perspective.
F Ehmann, L Caneva, K Prasad, M Paulmichl, M Maliepaard, A Llerena, M Ingelman-Sundberg, M Papaluca-Amati. Pharmacogenomics J 2015
78
33



Tailoring drug therapy based on genotype.
Larisa H Cavallari. J Pharm Pract 2012
7
33

Pharmacogenetic information for patients on drug labels.
Susanne B Haga, Rachel Mills, Jivan Moaddeb. Pharmgenomics Pers Med 2014
10
33

Changes and determination of dosing recommendations for medicinal products recently authorised in the European Union.
Falk Ehmann, Marisa Papaluca, Francesca Di Giuseppe, Luca Pani, Andrea Eskova, Efthymios Manolis, Ralf Herold. Expert Opin Pharmacother 2015
6
33


Clinical and regulatory considerations in pharmacogenetic testing.
Robert N Schuck, Elizabeth Marek, Hobart Rogers, Michael Pacanowski. Am J Health Syst Pharm 2016
4
33

Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey.
Nataša Karas Kuželički, Irena Prodan Žitnik, David Gurwitz, Adrian Llerena, Ingolf Cascorbi, Sofia Siest, Maurizio Simmaco, Marc Ansari, Mario Pazzagli, Chiara Di Resta,[...]. Pharmacogenomics 2019
27
33

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
500
33

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
R Dummer, A Hauschild, N Lindenblatt, G Pentheroudakis, U Keilholz. Ann Oncol 2015
240
33

Pharmacogenomics in oncology care.
Kelly K Filipski, Leah E Mechanic, Rochelle Long, Andrew N Freedman. Front Genet 2014
16
33

Consistency of drug-drug and gene-drug interaction information in US FDA-approved drug labels.
Daniela J Conrado, Hobart L Rogers, Issam Zineh, Michael A Pacanowski. Pharmacogenomics 2013
23
33


Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.
Joseph P Kitzmiller, David K Groen, Mitch A Phelps, Wolfgang Sadee. Cleve Clin J Med 2011
70
33



Isolated populations and complex disease gene identification.
Kati Kristiansson, Jussi Naukkarinen, Leena Peltonen. Genome Biol 2008
91
33

Genetic Polymorphisms of Pharmacogenomic VIP Variants in the Circassian Subpopulation from Jordan.
Laith N Al-Eitan, Namarg N Mohammad, Haneen W Al-Maqableh, Nancy M Hakooz, Rana B Dajani. Curr Drug Metab 2019
5
33

Ethnic differences in pharmacogenetically relevant genes.
R M Engen, S Marsh, D J Van Booven, H L McLeod. Curr Drug Targets 2006
46
33

Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population.
T B Jin, X J Xun, X G Shi, D Y Yuan, T Feng, T T Geng, L L Kang. Genet Mol Res 2015
6
33

The pharmacogenetics research network: from SNP discovery to clinical drug response.
K M Giacomini, C M Brett, R B Altman, N L Benowitz, M E Dolan, D A Flockhart, J A Johnson, D F Hayes, T Klein, R M Krauss,[...]. Clin Pharmacol Ther 2007
158
33


Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
Chan Zhang, Weiwei Guo, Yujing Cheng, Qi Li, Xin Yang, Run Dai, Linhao Zhu, Wanlu Chen. Mol Genet Genomic Med 2019
3
33

Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.
Negin Zand, Nader Tajik, Alireza Salek Moghaddam, Iraj Milanian. Clin Exp Pharmacol Physiol 2007
50
33

The population genetics of pharmacogenomics VIP variants in the Sherpa population.
Li Wang, Yongchao Ren, Xugang Shi, Dongya Yuan, Kai Liu, Tingting Geng, Gang Li, Longli Kang, Tian-Bo Jin. Drug Metab Pharmacokinet 2016
6
33

Screening for 392 polymorphisms in 141 pharmacogenes.
Jason Yongha Kim, Hyun Sub Cheong, Tae-Joon Park, Hee Jung Shin, Doo Won Seo, Han Sung Na, Myeon Woo Chung, Hyoung Doo Shin. Biomed Rep 2014
9
33

Genetic Polymorphisms of Pharmacogenes among the Genetically Isolated Circassian Subpopulation from Jordan.
Laith N Al-Eitan, Doaa M Rababa'h, Nancy M Hakooz, Mansour A Alghamdi, Rana B Dajani. J Pers Med 2020
5
33


Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
Fabiana D V Genvigir, Alvaro M Nishikawa, Claudia R Felipe, Helio Tedesco-Silva, Nagilla Oliveira, Antony B C Salazar, Jose O Medina-Pestana, Sonia Q Doi, Mario H Hirata, Rosario D C Hirata. Pharmacotherapy 2017
19
33


Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study.
Christopher Newton-Cheh, Chao-Yu Guo, Martin G Larson, Stacy L Musone, Aarti Surti, Amy L Camargo, Jared A Drake, Emelia J Benjamin, Daniel Levy, Ralph B D'Agostino,[...]. Circulation 2007
68
33


Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.
Valentine J Burroughs, Randall W Maxey, Richard A Levy. J Natl Med Assoc 2002
139
33

Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes.
Lionel Drocourt, Jean-Claude Ourlin, Jean-Marc Pascussi, Patrick Maurel, Marie-José Vilarem. J Biol Chem 2002
264
33

A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.
King Leung Fung, Michael M Gottesman. Biochim Biophys Acta 2009
235
33


The Impact of Potassium Channel Gene Polymorphisms on Antiepileptic Drug Responsiveness in Arab Patients with Epilepsy.
Laith N Al-Eitan, Islam M Al-Dalalah, Afrah K Elshammari, Wael H Khreisat, Ayah Y Almasri. J Pers Med 2018
10
33



Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case-control study.
Laith N Al-Eitan, Islam M Al-Dalalah, Mohamed M Mustafa, Mansour A Alghamdi, Afrah K Elshammari, Wael H Khreisat, Mohammed N Al-Quasmi, Hanan A Aljamal. Pharmgenomics Pers Med 2019
3
33

The human intestinal cytochrome P450 "pie".
Mary F Paine, Heather L Hart, Shana S Ludington, Robert L Haining, Allan E Rettie, Darryl C Zeldin. Drug Metab Dispos 2006
554
33




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.